US Patent 9926544 Chimeric alkaline phosphatase-like proteins
Patent 9926544 was granted and assigned to AM-Pharma B.V. on March, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+232 characters)
Article
Patent abstract
The invention relates to improved alkaline phosphatases, pharmaceutical compositions comprising improved alkaline phosphatases and the use of improved alkaline phosphatases for preventing, treating or curing diseases.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Andrea Van Elsas0
Erik Jan Van Den Berg0
José Luis Millán0
Luigi Johannes Cornelius Jonk0
Willem Raaben0
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09926544 Chimeric alkaline phosphatase-like proteins US Patent 9926544 Chimeric alkaline phosphatase-like proteins
Infobox
Patent Number
099265440
Patent Number
99265440
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
099265440
Date of Patent
March 27, 2018
0Patent Application Number
151136960
Date Filed
January 26, 2015
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09926544 Chimeric alkaline phosphatase-like proteins
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09926544
Date of patent
March 27, 2018
Patent application number
15113696
Date Filed
January 26, 2015
Patent primary examiner
Find more entities like US Patent 9926544 Chimeric alkaline phosphatase-like proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
